We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
1026
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.45M 0.01%
12,767
-514
-4% -$42.7K
WSFS icon
1027
WSFS Financial
WSFS
$4.17B
$1.45M 0.01%
32,039
-2,075
-6% -$97.6K
FSS icon
1028
Federal Signal
FSS
$7.51B
$1.45M 0.01%
31,233
-572
-2% -$26.2K
COOP
1029
DELISTED
Mr. Cooper
COOP
$1.45M 0.01%
36,015
-1,469
-4% -$62K
EBC icon
1030
Eastern Bankshares
EBC
$5.37B
$1.44M 0.01%
83,768
SKY icon
1031
Champion Homes
SKY
$5.23B
$1.44M 0.01%
28,047
BECN
1032
DELISTED
Beacon Roofing Supply, Inc.
BECN
$1.43M 0.01%
27,132
LXP icon
1033
LXP Industrial Trust
LXP
$3.58B
$1.43M 0.01%
28,531
-1,613
-5% -$80.6K
KD icon
1034
Kyndryl
KD
$3.04B
$1.43M 0.01%
128,516
-2,515
-2% -$25.3K
ELF icon
1035
e.l.f. Beauty
ELF
$5.43B
$1.42M 0.01%
25,725
-699
-3% -$34.2K
PTCT icon
1036
PTC Therapeutics
PTCT
$6.01B
$1.42M 0.01%
37,180
BCC icon
1037
Boise Cascade
BCC
$2.94B
$1.42M 0.01%
20,649
-299
-1% -$20.4K
INSM icon
1038
Insmed
INSM
$27.6B
$1.42M 0.01%
70,839
+7,955
+13% +$154K
MHK icon
1039
Mohawk Industries
MHK
$9.42B
$1.41M 0.01%
13,766
-227
-2% -$22.3K
KFY icon
1040
Korn Ferry
KFY
$4.36B
$1.41M 0.01%
27,783
-790
-3% -$42K
ALK icon
1041
Alaska Air
ALK
$5.3B
$1.41M 0.01%
32,726
-527
-2% -$23.2K
MQ icon
1042
Marqeta
MQ
$1.71B
$1.4M 0.01%
57,424
-1,696
-3% -$46.3K
AUB icon
1043
Atlantic Union Bankshares
AUB
$6.09B
$1.4M 0.01%
39,931
ACA icon
1044
Arcosa
ACA
$7.12B
$1.4M 0.01%
25,769
HBI
1045
DELISTED
Hanesbrands
HBI
$1.4M 0.01%
219,694
-4,394
-2% -$30.2K
BKU icon
1046
Bankunited
BKU
$3.41B
$1.39M 0.01%
41,005
BPMC
1047
DELISTED
Blueprint Medicines
BPMC
$1.39M 0.01%
31,782
CWEN icon
1048
Clearway Energy Class C
CWEN
$7.02B
$1.39M 0.01%
43,656
VRNS icon
1049
Varonis Systems
VRNS
$5.26B
$1.39M 0.01%
58,102
ESGR
1050
DELISTED
Enstar Group
ESGR
$1.39M 0.01%
6,002

Similar funds

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.